ADAR1 Capital Management, LLC
10% Owner · 8 filings · Latest: Jul 30, 2026
InMed Pharmaceuticals Inc.
NextCure, Inc.
Rallybio Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NXTC | ADAR1 Capital Management, LLC | 10% Owner | Jul 31, 2026 | Purchase | $4.94 | 36,303 | $179.4K | 722,419 | |
NXTC | ADAR1 Capital Management, LLC | 10% Owner | Jul 30, 2026 | Purchase | $4.93 | 292,850 | $1.4M | 686,116 | |
NXTC | ADAR1 Capital Management, LLC | 10% Owner | Jul 29, 2026 | Purchase | $5.00 | 3,410 | $17.1K | 393,266 | |
NXTC | ADAR1 Capital Management, LLC | 10% Owner | Jul 28, 2026 | Purchase | $4.95 | 6,400 | $31.7K | 389,856 | |
NXTC | ADAR1 Capital Management, LLC | 10% Owner | Jul 27, 2026 | Purchase | $5.00 | 7,798 | $39.0K | 383,456 | |
INM | ADAR1 Capital Management, LLC | 10% Owner | Jul 15, 2026 | Purchase | $1.56 | 1,000 | $1.6K | 801,000 | |
INM | ADAR1 Capital Management, LLC | 10% Owner | May 19, 2026 | Purchase | $1.54 | 468,551 | $721.5K | 800,000 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 19, 2026 | Purchase | $13.98 | 10,200 | $142.6K | 926,352 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 18, 2026 | Purchase | $13.98 | 6,009 | $84.0K | 916,152 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 15, 2026 | Purchase | $13.90 | 300 | $4.2K | 910,143 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 13, 2026 | Purchase | $13.99 | 79,259 | $1.1M | 909,843 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 12, 2026 | Purchase | $13.83 | 800 | $11.1K | 830,584 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 11, 2026 | Purchase | $14.00 | 50,000 | $700.0K | 829,784 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 5, 2026 | Purchase | $14.00 | 35,101 | $491.3K | 779,784 | |
RLYB | ADAR1 Capital Management, LLC | 10% Owner | May 4, 2026 | Purchase | $13.97 | 120,804 | $1.7M | 744,683 |